Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael F Pollack, MS
AstraZeneca
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Mississauga, Canada
Not, yet, recruiting
- Research Site
Hamburg, Germany
Recruiting
- Research Site
Athens, Greece
Recruiting
- Research Site
Milan, Italy
Recruiting
- Research Site
Tokyo, Japan
Recruiting
- Research Site
Bucharest, Romania
Not, yet, recruiting
- Research Site
London, United Kingdom
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Apr 2025
- Primary completion
- 14 Dec 2026
- Completion
- 14 Dec 2026
- Last update posted
- 16 Jun 2026
- Registered enrollment
- 2,000
- Registry id
- NCT06712563
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.